More and more Americans are going to India to seek treatment for their various health conditions. It’s because India is the hotspot for the latest experimental embryonic stem cell therapy performed by a retired obstetrician and stem cell practitioner, Dr. Geeta Shroff at New Delhi’s NuTech Mediworld.
One of the many American patients who sought treatment was Cash Burnaman, six years old from South Carolina. He has a very rare health condition. According to a report he has to take artificial growth hormones in order to survive.
When they heard about embryonic stem cells therapy, his parents decided to let him undergo experimental injection of human embryonic stem cells. Dr. Stroff first treated Cash in 2010. The first treatment took five weeks and after they went home to the US, his parents said that was the first time Cash began walking with the support of braces.
According to Dr. Stroff, she charged her 87 American patients around $25,000 for four to five weeks of treatment.
However, there are health experts who claimed that the treatment she’s offering has no medical benefits at all. There is no sufficient evidence that embryonic stem cells treatment is reliable and effective.
But this didn’t stop Dr. Stroff from treating her patients. According to her, the success rate of embryonic stem cells treatment she conducted is currently over 90 percent.